In conclusion, results of the present study provide experimental evidence that myricetin can inhibit invasion and migration of radioresistant lung cancer cells (A549‐IR) by suppressing the expression of MMP‐2 and MMP‐9 through inhibition of the FAK‐ERK signaling pathway. Here, PTK2 is linked to lung carcinoma.